By Dr. Charles Kamen, MD — Board-Certified Neurologist, LiveWell21, Las Vegas, NV
Albert Einstein College of Medicine (MD, 2011) | Yale-New Haven Hospital Internship (2011–2012) | Loma Linda University Neurology Residency (2015–2018) | ABPN Board Certified
Patients ask me this question regularly, and I appreciate that they're asking it — because it's the right question to be asking. Both "IV therapy is just expensive urine" and "IV therapy is dramatically superior to anything you can take by mouth" are oversimplifications that don't serve patients well.
The honest answer requires engaging with some pharmacology, some physiology, and some clinical context. So let me give you that answer — without the marketing spin in either direction.
I offer both IV nutrition therapy and evidence-supported oral supplementation protocols at LiveWell21 in Las Vegas. I use both, often in the same patient, often for different goals. The question I ask is always the same: given this patient's clinical situation, what delivery route makes sense?
Before comparing IV to oral, it helps to understand what happens to a supplement after you swallow it.
Oral absorption is a multistep process:
Each of these steps reduces the amount that actually reaches your cells — and each can be disrupted by GI conditions, medications, genetic variants, or simply high doses that exceed absorptive capacity.
Intravenous delivery bypasses all of this. The nutrient enters systemic circulation directly — 100% bioavailability, near-immediate distribution to tissues, no absorption limits, no first-pass metabolism. This is the fundamental pharmacological argument for IV delivery, and in specific clinical contexts it's a compelling one.
But "bypasses the GI tract" is not automatically an advantage for every nutrient in every patient. The GI tract also performs important regulatory functions — slowing absorption of certain compounds, regulating how much is taken up relative to what's already stored, and providing a buffered delivery that prevents abrupt concentration spikes. For some nutrients, that buffering is actually desirable.
This is the clearest case for IV superiority, and it's well-established in the pharmacokinetic literature. Padayatty and colleagues at NIH demonstrated that oral vitamin C is tightly regulated: plasma concentrations plateau around 220 μmol/L regardless of dose beyond approximately 1,000 mg per day, because intestinal absorption saturates and renal excretion increases.1
With IV administration, plasma concentrations can reach 15,000–20,000 μmol/L — 50 to 70 times higher than what oral dosing can achieve. At these concentrations, vitamin C behaves differently than it does at dietary levels. It generates hydrogen peroxide in extracellular fluid through pro-oxidant mechanisms that are selectively toxic to certain cells (a proposed mechanism in integrative oncology applications). It exerts more pronounced antioxidant and anti-inflammatory effects. For clinical applications where high plasma concentration is the therapeutic goal — immune support during serious illness, integrative oncology protocols, or antioxidant loading — oral vitamin C simply cannot reach the target concentrations.
For general antioxidant support and immune maintenance at normal physiological levels, oral vitamin C (500–1,000 mg daily) is entirely adequate and far more practical.
Oral magnesium supplementation is limited by two problems. First, intestinal absorption is incomplete and varies considerably based on the form of magnesium used (glycinate and malate absorb better than oxide; oxide is what's in most cheap supplements). Second, high oral doses reliably cause diarrhea — the GI tract uses osmotic mechanisms to excrete excess magnesium, which is actually the mechanism behind magnesium's use as a laxative.
This creates a practical ceiling on how much magnesium you can raise through oral supplementation without GI consequences. Many patients can absorb 200–400 mg daily in well-chosen forms without issue; getting substantially higher requires IV delivery.
For patients with migraines (where IV magnesium has the strongest evidence base — the American Headache Society recommends IV magnesium for acute migraine in emergency settings2), or those with documented magnesium deficiency that hasn't responded to oral repletion, IV delivery achieves tissue saturation that oral dosing cannot.
For maintenance supplementation in healthy patients without severe deficiency, oral magnesium glycinate or malate at 300–400 mg daily is an entirely reasonable approach.
Oral glutathione has notoriously poor bioavailability. The tripeptide is largely broken down by peptidases in the GI tract — particularly gamma-glutamyl transferase — before it can be absorbed intact. Liposomal oral formulations have improved on this somewhat, but systemic delivery remains substantially inferior to IV.
For patients wanting to meaningfully raise systemic glutathione levels, IV administration is the most reliable approach. Oral N-acetylcysteine (NAC) is a reasonable alternative for those who want oral supplementation — it's a glutathione precursor that's well-absorbed and effectively raises intracellular glutathione synthesis.
For most people with adequate gastric acid production, oral B12 at sufficient doses (1,000 mcg or more daily) achieves adequate absorption through passive diffusion even when the active intrinsic factor pathway is impaired. But for patients with severe B12 deficiency, pernicious anemia, significant atrophic gastritis, post-bariatric surgery anatomy, or those on long-term proton pump inhibitors, IV or intramuscular B12 bypasses the absorption problem entirely and replenishes stores faster.
Inflammatory bowel disease, celiac disease, short bowel syndrome, and post-bariatric surgery anatomy all impair nutrient absorption to varying degrees. For these patients, oral supplementation — even in high doses — may be inadequate. IV nutrition therapy isn't just preferable in these cases; it may be the only way to achieve therapeutic repletion.
I want to be direct about this, because there's a tendency in some IV wellness marketing to imply that oral supplementation is almost worthless. That's not accurate, and it doesn't serve patients well.
Vitamin D3 is a fat-soluble vitamin with excellent oral bioavailability when taken with food. Multiple clinical trials have demonstrated that oral vitamin D3 at doses of 2,000–5,000 IU daily reliably raises 25-OH vitamin D levels in deficient patients to adequate ranges. There is no meaningful clinical rationale for IV vitamin D in most patients — oral supplementation works, it's cheap, and it's safe.
High-quality fish oil or algal DHA/EPA supplements are well-absorbed orally. The omega-3 index — the percentage of EPA and DHA in red blood cell membranes — reliably improves with consistent oral supplementation at adequate doses (2–4 grams daily of combined EPA/DHA). There is no IV formulation that offers meaningful advantage over oral omega-3s for most patients.
NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are well-absorbed orally and have been shown in clinical trials to meaningfully raise circulating NAD+ levels. For patients who want ongoing NAD+ support between IV infusions, or those who want to maintain elevated NAD+ levels with daily supplementation, oral precursors are a legitimate and evidence-supported option.
IV NAD+ achieves higher plasma concentrations and more rapid cellular repletion — it's a therapeutic loading dose rather than daily maintenance. The two approaches are complementary, not competing.
For patients with intact GI function and no malabsorption issues, oral B-complex supplementation is effective for correcting moderate B vitamin insufficiency. The exception is B12 in patients with absorption problems, as discussed above.
Oral forms of these minerals at appropriate doses are adequately absorbed in most patients. IV supplementation of trace minerals is rarely necessary outside of clinical malnutrition or specific malabsorption conditions.
IV therapy is more expensive than oral supplementation — that's simply true. A Myers' Cocktail or NAD+ infusion requires a clinic visit, nursing time, pharmaceutical-grade compounds, and appropriate medical oversight. None of that is free.
The question is whether the additional cost is justified by additional clinical benefit. My general framework:
One variable that the IV vs. oral comparison doesn't address is supplement quality — and it matters considerably on the oral side.
The dietary supplement industry in the United States is loosely regulated. Third-party testing organizations (NSF International, USP, ConsumerLab) consistently find that a meaningful percentage of supplements contain less of the stated ingredient than the label claims, or contain contaminants. This variability is absent with pharmaceutical-grade IV compounding, where potency and sterility are rigorously controlled.
When I recommend oral supplements, I specify products with third-party verification. The difference between a well-formulated, verified oral supplement and an unreliable one is larger than the difference between IV and oral for many nutrients. Choosing your oral supplements carefully closes much of the gap.
At LiveWell21, every recommendation is individualized. I don't have a standard template for who gets IV vs. oral, because the right answer depends on:
What I don't do is recommend IV therapy as a categorical upgrade over oral supplementation for everyone. That's not medicine — it's a sales pitch. For the right patient with the right clinical indication, IV therapy is genuinely superior. For others, well-chosen oral supplementation guided by bloodwork achieves the same outcome at a fraction of the cost.
Knowing which is which — that's what the physician evaluation is for.
If you're in the Las Vegas area and want a clear-eyed, evidence-based recommendation about whether IV nutrition therapy, oral supplementation, or a combination is right for your situation, I'd welcome the conversation. We'll start with your labs, review your history, and build a recommendation grounded in your actual biology — not a protocol designed to maximize clinic revenue.
That's the approach I take with every patient at LiveWell21.
Book a Consultation at LiveWell21
Explore our related services:
Complete Guide to IV Nutrition Therapy | NAD+ IV Therapy for Brain Health | Bloodwork & Advanced Diagnostics | Peptide Therapy
This content is for educational purposes and does not constitute medical advice. Consult a qualified physician before beginning any IV therapy or supplementation program.